Dose-Intensified Combined Modality Treatment with 2 Cycles of BEACOPP Escalated Followed by 2 Cycles of ABVD and IF-RT in Patients with Early Unfavourable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

• Authors: BORCHMANN P.; ENGERT A.; PLUETSCHOW A.; FLUCHS M.; MARKOVA J.; LOHRI A.; KRÁL Zdeněk; GREIL R.; TOPP M.; VILLALOBOS M.; ZIJLSTRA J.; SOEKLER M.; STEIN H.; EICH H.; MUELLER R.; DIEHL V.
• Year of publication: 2008
• Type: Article in Periodical
• Magazine / Source: Blood
• MU Faculty or unit: Faculty of Medicine